Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

STEMI 2022 thumbnail 1

STEMI Watch 2022

Price: $199.00

Product Details

Written with Mission: Lifeline® hospitals in mind, STEMI 2022: Strategic Advances provides physicians and staff with a concise and practical update on ST-segment elevation myocardial infarction (STEMI). In the seventh edition of this series, you'll gain valuable STEMI CME/CE while reviewing clinically relevant recommendations to improve consistency of cardiac care for patients.

Complete with tables, treatment algorithms, and ECG strips, STEMI 2022 is presented in five online modules allowing for per-module CME/CE testing. Gain insight on STEMI diagnosis, ECG analysis and review, legal issues, and more.

In the United States, someone has a heart attack every 43 seconds, and someone dies from heart disease every 90 seconds. STEMI 2022 provides tools to help you and your staff make positive changes.

Features:

  • Expertly written articles on evidence-based treatments for STEMI
  • Valuable ECG images with interpretation from experts
  • Concise targeted articles that summarize the latest research and provide clinically relevant recommendations to improve patient care
  • Opportunity to earn up to 10 AMA PRA Category 1 Credits or ANCC credits
Benefits include:
  • Improve the consistency of cardiac care for STEMI patients.
  • Gain proven strategies to eliminate obstacles that prevent STEMI patients from accessing and receiving appropriate treatments.
  • Easy module format for physicians and nurses to earn self-paced continuing education credits.
  • Concise PDF format for convenient offline learning.

Table of Contents

Module 1: Diagnosis and Initial Therapy
Module 2: ECG Analysis and Review
Module 3: Prevention, Evaluation, and Therapy
Module 4: Treatment and Management
Module 5: Legal and Ethical Issues

Contact us for custom reprints and group sales opportunities.

Faculty:

Physician Editor:
Michael H. Crawford, MD
Professor of Medicine
Chief of Clinical
Cardiology University of California, San Francisco

Physician Peer Reviewers:

Elaine Chen, MD
Assistant Professor, Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Section of Palliative Medicine, Rush University Medical Center, Chicago

Gerald Roberts, MD
Senior Attending Physician, Long Island Jewish Medical Center, NS/LIJ Health Care System, New Hyde Park, NY

Steven M. Winograd, MD, FACEP
Attending Emergency Physician, Keller Army Community Hospital, West Point, NY

Susan Zhao, MD
Director, Adult Echocardiography Laboratory
Associate Chief, Division of Cardiology, Department of Medicine, Santa Clara Valley Medical Center, Santa Clara, CA

Nurse Planners:

Jane Guttendorf, DNP, RN, CRNP, ACNPBC, CCRN
Assistant Professor, Acute & Tertiatry Care, University of Pittsburgh, School of Nursing

Nicole Huff, MBA, MSN, RN, CEN
Director, Emergency and Trauma Services, Gunnison Valley Health, Gunnison, CO

Aurelia Macabasco-O’Connell, PhD, ACNP-BC, RN, PHN, FAHA
Associate Professor, Azusa Pacific University School of Nursing, Azusa, CA

Susan Solverson, BSN, RN, CMSRN
Grafton, WI

Accreditation & Credit Designation Statements:

Joint provider logo

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Relias LLC designates this enduring material for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

10 ANCC contact hours will be awarded to participants who meet the criteria for successful completion. California Board of Registered Nursing, Provider CEP#13791.

Activity Objectives:

After reading STEMI 2022: Strategic Advances in Care, the participant will be able to:

  1. Discuss current scientific research and data regarding the diagnosis of ST-segment elevation myocardial infarction (STEMI).
  2. Discuss the pathogenesis and treatment of STEMI.
  3. Cite new information regarding new drugs for STEMI and new uses for traditional drugs.
  4. Identify ancillary issues of importance for healthcare providers who treat STEMI patients.
  5. Discuss advance in STEMI treatment.

How to Earn Credits:

Physicians and nurses participate in this CME/CE activity by reading the articles, using the provided references for further research, and studying the relevant questions at the end each module Participants will then be directed to a website, where they will complete an online assessment to show what they’ve learned. They must score 80% on the assessment to complete the activity, but they are allowed to answer the questions multiple times if needed. After they have successfully completed the assessment, they will be directed to an online activity evaluation form. Once that is submitted, they will receive their credit letter.

Target Audience:

This activity is intended for cardiologists, coronary care nurses and staff, emergency medicine physicians and nurses, emergency medical service providers, ECG staff, percutaneous coronary intervention center staff, and freestanding emergency department staff.

Expiration: March 30, 2025

ISBN: 978-1-941481-67-7

Product Code: E22249

Price: $199.00

STEMI Watch 2022

Price: $199